Back to top
more

Inter Parfums (IPAR)

(Delayed Data from NSDQ)

$119.11 USD

119.11
134,212

+0.55 (0.46%)

Updated May 3, 2024 04:00 PM ET

After-Market: $119.11 0.00 (0.00%) 7:58 PM ET

Zacks Rank:

This is our short term rating system that serves as a timeliness indicator for stocks over the next 1 to 3 months. How good is it? See rankings and related performance below.

Zacks Rank Definition Annualized Return
1Strong Buy24.20%
2Buy18.04%
3Hold9.52%
4Sell5.20%
5Strong Sell2.60%
S&P50011.13%

Zacks Rank Education - Learn about the Zacks Rank

Zacks Rank Home - Zacks Rank resources in one place

Zacks Premium - The only way to fully access the Zacks Rank

4-Sell of 5       4  

Style Scores:

The Style Scores are a complementary set of indicators to use alongside the Zacks Rank. It allows the user to better focus on the stocks that are the best fit for his or her personal trading style.

The scores are based on the trading styles of Value, Growth, and Momentum. There's also a VGM Score ('V' for Value, 'G' for Growth and 'M' for Momentum), which combines the weighted average of the individual style scores into one score.

Value Score A
Growth Score A
Momentum Score A
VGM Score A

Within each Score, stocks are graded into five groups: A, B, C, D and F. As you might remember from your school days, an A, is better than a B; a B is better than a C; a C is better than a D; and a D is better than an F.

As an investor, you want to buy stocks with the highest probability of success. That means you want to buy stocks with a Zacks Rank #1 or #2, Strong Buy or Buy, which also has a Score of an A or a B in your personal trading style.

Zacks Style Scores Education - Learn more about the Zacks Style Scores

D Value B Growth B Momentum B VGM

Industry Rank:

The Zacks Industry Rank assigns a rating to each of the 265 X (Expanded) Industries based on their average Zacks Rank.

An industry with a larger percentage of Zacks Rank #1's and #2's will have a better average Zacks Rank than one with a larger percentage of Zacks Rank #4's and #5's.

The industry with the best average Zacks Rank would be considered the top industry (1 out of 265), which would place it in the top 1% of Zacks Ranked Industries. The industry with the worst average Zacks Rank (265 out of 265) would place in the bottom 1%.

Zacks Rank Education -- Learn more about the Zacks Rank
Zacks Industry Rank Education -- Learn more about the Zacks Industry Rank

Bottom 12% (222 out of 252)

Industry: Cosmetics

Zacks Premium FeatureView All Zacks #1 Ranked Stocks

Better trading starts here.

Zacks News

The J.M. Smucker (SJM) Q3 Earnings Coming Up: Factors to Note

by Zacks Equity Research

The J.M. Smucker's (SJM) fiscal third-quarter results are likely to reflect gains from pricing and brand strength, along with the impacts of the Hostess Brands buyout.

Earnings Preview: Olaplex Holdings, Inc. (OLPX) Q4 Earnings Expected to Decline

by Zacks Equity Research

Olaplex Holdings, Inc. (OLPX) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.

Monster Beverage (MNST) Looks Poised for Earnings Beat in Q4

by Zacks Equity Research

Monster Beverage (MNST) Q4 results are expected to reflect gains from the strong energy drinks category, product launches, innovation, pricing actions and the easing of supply-chain headwinds.

Can Boston Beer (SAM) Beat Q4 Earnings Amid Soft Shipments?

by Zacks Equity Research

Boston Beer (SAM) Q4 results are expected to reflect gains from robust trends for its twisted tea brand, premiumization, innovation and growth of its Beyond Beer category.

Zacks Industry Outlook Highlights Estee Lauder, Coty, Inter Parfums, and Helen of Troy

by Zacks Equity Research

Estee Lauder, Coty, Inter Parfums, and Helen of Troy have been highlighted in this Industry Outlook article.

International Flavors (IFF) Q4 Earnings Lag Estimates, Dip Y/Y

by Zacks Equity Research

International Flavors' (IFF) Q4 top line reflects softness in the Pharma and Nourish segments, offset by growth in the Scent, and Health & Biosciences segments.

Medifast (MED) Q4 Earnings Beat Estimates, Revenues Dip Y/Y

by Zacks Equity Research

Medifast's (MED) Q4 results reflect the impacts of poor customer acquisition. However, it is showing resilience, banking on its strategic focus on medically supported weight loss, indicating potential for growth.

Things to Note Ahead of Inter Parfums' (IPAR) Q4 Earnings

by Zacks Equity Research

Inter Parfums' (IPAR) fourth-quarter 2023 performance will likely reflect the adverse impact of rising advertising and promotion costs. Nevertheless, a solid brand portfolio is likely to aid growth.

Ansuiya Mohta headshot

4 Cosmetics Stocks Worth Watching on Robust Industry Trends

by Ansuiya Mohta

The Zacks Cosmetics industry companies are benefiting from a burgeoning demand for skincare and personal care products. Focus on innovations is propelling The Estee Lauder Companies (EL), COTY, Inter Parfums (IPAR) and Helen of Troy (HELE).

Pilgrim's Pride (PPC) Q4 Earnings Coming Up: Factors to Note

by Zacks Equity Research

Pilgrim's Pride (PPC) witnesses strength in its Mexico and Europe operations. A focus on key customers and supply-chain improvements work well for the company.

Can Cheniere (LNG) Pull Off a Strong Show in Q4 Earnings?

by Zacks Equity Research

Robust export volumes and lower costs are likely to have boosted Cheniere Energy's (LNG) profit levels in the fourth quarter.

Itron (ITRI) to Post Q4 Earnings: Here's What You Should Know

by Zacks Equity Research

Itron's (ITRI) fourth-quarter performance is likely to have benefited from continued momentum across all business segments.

Factors to Note Ahead of Coterra Energy's (CTRA) Q4 Earnings

by Zacks Equity Research

Coterra Energy (CTRA) beat the Zacks Consensus Estimate for earnings in each of the last four quarters, resulting in an earnings surprise of 111.8%, on average.

Inter Parfums (IPAR) Expected to Beat Earnings Estimates: Should You Buy?

by Zacks Equity Research

Inter Parfums (IPAR) possesses the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.

Suncor's (SU) Q4 Earnings Preview: Key Things to Consider

by Zacks Equity Research

Suncor Energy (SU) beat the Zacks Consensus Estimate for earnings in each of the last four quarters.

Wolverine (WWW) Q4 Earnings Coming Up: Factors Worth Knowing

by Zacks Equity Research

Wolverine (WWW) battles challenges in the outdoor category, soft demand in the U.S. and European wholesale businesses and weakness in the DTC channel.

Here's How FEMSA (FMX) is Placed Just Ahead of Q4 Earnings

by Zacks Equity Research

FEMSA's (FMX) Q4 results are expected to reflect effective growth strategies and robust market demand, which are likely to drive growth across all units.

Helen of Troy (HELE) Benefits From Brand Strength & Project Pegasus

by Zacks Equity Research

Helen of Troy (HELE) is on track with Project Pegasus, which aims to expand operating margins via improved efficiency and lower costs.

What's in the Cards for Keurig Dr Pepper (KDP) in Q4 Earnings?

by Zacks Equity Research

Keurig Dr Pepper's (KDP) fourth-quarter 2023 results are likely to reflect gains from brand strength, significant pricing actions and a solid performance in its cold beverages.

Marathon (MRO) Q4 Earnings on Deck: Here's How It Will Fare

by Zacks Equity Research

Lower commodity price realizations and the increase in costs are likely to have impacted the fourth-quarter earnings of Marathon Oil (MRO).

TreeHouse Foods (THS) Q4 Earnings Beat, Sales Decline Y/Y

by Zacks Equity Research

TreeHouse Foods' (THS) fourth-quarter fiscal 2023 results reflect soft sales and earnings due to supply-chain hurdles at one of the broth facilities.

International Flavors (IFF) to Post Q4 Earnings: What's in Store?

by Zacks Equity Research

International Flavors' (IFF) Q4 results are likely to reflect the impacts of lower volumes and escalating costs.

Service Corp (SCI) Hikes Dividend: What Else Should You Know?

by Zacks Equity Research

Service Corp (SCI) announces a dividend increase, showcasing its commitment to delivering value to its shareholders.

Medifast (MED) Q4 Earnings Coming Up: What Should You Know?

by Zacks Equity Research

Medifast's (MED) fourth-quarter results are likely to reflect the impacts of macroeconomic challenges like inflation, while key growth initiatives like innovation bode well.

Is Inter Parfums (IPAR) Stock Outpacing Its Consumer Staples Peers This Year?

by Zacks Equity Research

Here is how Inter Parfums (IPAR) and Kerry Group PLC (KRYAY) have performed compared to their sector so far this year.